Home > Publications > CBCRP Annual Reports — 1999 > Summary of 1999 Research Awards

Summary of 1999 Research Awards

1999 was the California Breast Cancer Research Program's fifth year of operation, and marked another year of important achievements and growth for the BCRP. With a budget of $17,432,000, BCRP was able to award 62 new projects across the state. The projects include work in the areas of:

the biology of the normal breast,
factors that increase the risk of breast cancer,.
ways to reduce the risk of breast cancer,
understanding how breast cancer develops,.
developing new treatments for breast cancer,
detecting breast cancer earlier.
exploring socio-cultural, behavioral, and psychological aspects of breast cancer

California Institute of Technology	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Brown, Eric Role of a DNA Damage Response Gene in Breast Cancer	2.0	$70,000	$0	$70,000

California Pacific Medical Center Research Institute	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Desprez, Pierre-Yves Id-1 Expression During Breast Cancer Progression	1.0	$49,988	$28,043	$78,031
Singh, Jarnail Identification of Novel Id-1 Regulated Genes in Breast Cells	2.0	$70,000	$5,600	$75,600
SUBTOTAL		$119,988	$33,634	$153,631

Cedars-Sinai Medical Center	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Davis, Vicki Breast Cancer Prevention by a Dominant Negative ER Variant	2.0	$199,989	$102,994	$302,983
Koeffler, H. Phillip Identification of Novel Secreted Proteins of Breast Cancer	1.0	$50,000	$25,750	$75,750
SUBTOTAL		$249,989	$128,744	$378,733

City of Hope National Medical Center	DURATION	DIRECT COST	INDIRECT COST	TOTAL
MacDonald, Deborah Communication, Content & Impact of Genetics in Breast Cancer	3.0	$427,442	$203,732	$631,174

John Wayne Cancer Institute	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Hoon, Dave Clinical Utility of Breast Cancer DNA Markers in Plasma	2.0	$197,762	$175,613	$373,375

Kaiser Permanente Southern California	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Enger, Shelley Can Molecular Markers Predict Response to Adjuvant Therapy?	3.0	$206,166	$66,486	$272,652

La Loba Support Group	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Kreshka, Mary Anne (Sub-contract to Stanford University)	3.0	$0	$0	$0

Lawrence Berkeley National Laboratory	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Hagios, Carmen Hox Genes in Normal Breast Development and Breast Cancer	2.0	$70,000	$0	$70,000

Lawrence Livermore National Laboratory	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Albala, Joanna A Role for Rad51B in Breast Cancer	3.0	$225,000	$182,787	$407,787

Marin Breast Cancer Watch	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Farren, Georgianna Marin County Breast Cancer Study of Adolescet Risk Factors	2.5	$215,000	$31,800	$246,800

Molecular Medicine Research Institute	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Beyene, Yewoubdar Belief and Risks of Breast Cancer Among African Immigrants	2.0	$236,873	$0	$236,873

The Orange County Asian and Pacific Islander Community Alliance	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Mary Anne Foo / Sora Park Tanjasiri Belief and Risks of Breast Cancer Among African Immigrants (Sub-contract to University of California, Los Aneles)	3.0	$0	$0	$0

Salk Institute for Biological Studies	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Xie, Wen ACTR/A1B1 in Mammary Gland Development and Tumorigenesis	2.0	$70,000	$5,600	$75,600

Scripps Research Institute	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Felding-Habermann, Brunhilde Breast Cancer Cell Binding to the Endothelium	2.0	$197,759	$129,133	$326,892
Jackson, Janis Specificity of Ras Signaling in Breast Cancer	2.0	$150,000	$114,450	$264,450
Strohmaier, Heimo Proteolysis of Cyclin E in Normal and Malignant Breast Cells	2.0	$70,000	$5,600	$75,600
Wang, Xiaofei Mechanism of Radiosensitivity in Breast Cancer Cells	2.0	$70,000	$5,600	$75,600
SUBTOTAL		$487,759	$254,783	$742,542

Sidney Kimmel Cancer Center	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Schnitzer, Jan Targeting Breast Cancer Blood Vessels	2.0	$200,000	$192,600	$392,600

Stanford University	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Cordova, Matthew Do Community Cancer Groups Enhance Well-being?	2.0	$70,000	$5,600	$75,600
Hancock, Steven Breast Cancer Screening in Women Surviving Hodgkin's Disease	3.0	$716,626	$319,320	$1,035,946
Jackson, Peter Role of the POP1 Gene in Breast Cancer Genomic Stability	1.0	$75,000	$41,535	$116,535
Jeffrey, Stefanie Breast Cancer Gene Expression Using Amplified Core Biopsie	1.0	$100,000	$58,500	$158,500
Koopman, Cheryl A Support Group Alternative for Rural and Isolated Women	3.0	$491,009	$97,322	$588,331
Thompson, Devon Characterization of hAG-2 and Its Role in Breast Cancer	3.0	$225,000	$130,749	$355,749
Weigel, Ronald GATA-3 Expression of Hormone Responsive Breast Cancer	2.0	$150,000	$84,825	$234,825
Zhang, Hong Cloning of Senescence Genes in Mammary Epithelial Cells	2.0	$70,000	$5,600	$75,600
SUBTOTAL		$1,897,635	$743,451	$2,641,086

The Burnham Institute	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Ely, Kathryn Molecular Structure of BAG-1: a New Protein in Breast Cancer	2.0	$149,630	$142,148	$291,778
Kim, Youngsoo COX-2 and Apoptosis Regulation in Breast Cancer	2.0	$70,000	$5,600	$75,600
Pasquale, Elena Role of the EphB4 Receptor Tyrosine Kinase in Breast Cancer	2.0	$199,876	$189,882	$389,758
Smith, Jeffrey Protease Fingerprinting to Diagnose Breast Cancer	2.0	$148,895	$136,510	$285,405
Strongin, Alex Spatial Control of Matrix Proteolysis in Breast Cancer	2.0	$174,555	$165,828	$340,383
Sun, YingQing A Novel Inhibitor of Breast Tumor Angiogenesis	2.0	$70,000	$5,600	$75,600
Vuori, Kristiina How Does Endostatin Inhibit Breast Cancer Angiogenesis?	2.0	$150,022	$142,521	$292,543
SUBTOTAL		$962,978	$788,089	$1,751,067

University of California, Berkeley	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Firestone, Gary Indole Derivatives as Novel Breast Cancer Therapeutics	2.0	$150,000	$0	$150,000
Miller, Sheldon Mechanisms of Fluid Transport in Human Mammary Epithelium	2.0	$149,822	$0	$149,822
Zhang, Liqun JoAnn How Indole-3 Carbinol Inhibits Breast Cancer Cell Growth	2.0	$70,000	$0	$70,000
SUBTOTAL		$369,822	$0	$369,822

University of California, Davis	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Cardiff, Robert Oncogenes: Progression and Biomarkers	2.0	$144,609	$0	$144,609
Melnikow, Joy Tamoxifen Prevention: Is it Acceptable to Women at Risk?	2.0	$321,373	$0	$321,373
Winthrop, Michelle Bispecific Antibodies for Radiotherapy of Breast Cancer	2.0	$70,000	$0	$70,000
SUBTOTAL		$535,982	$0	$535,982

University of California, Irvine	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Michelle Tabb SXR: A Novel Target for Breast Cancer Therapeutics	2.0	$70,000	$0	$70,000

University of California, Los Angeles	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Barsky, Sanford A New Model for Inflammatory Breast Carcinoma	2.0	$200,000	$0	$200,000
Gallardo, Nilsa Social Support and Breast Cancer Control Among Latinas	2.0	$70,000	$0	$70,000
Kagawa-Singer, Marjorie Breast Health Project for Hmong Women and Men	3.0	$500,000	$0	$500,000
Kimme-Smith, Carolyn UCLA Biomedical Physics Graduate Training in Breast Cancer	3.0	$189,206	$0	$189,206
Nguyen, Mai Novel Breast Cancer Anti-Angiogenic Compounds	1.0	$69,227	$0	$69,227
Pietras, Richard New Radiation Therapy for HER-2-overexpressing Breast Cancer	2.0	$200,000	$0	$200,000
Premack, Brett Role of Chemokine Receptors in Breast Cancer Metastasis	1.0	$49,966	$0	$49,966
SUBTOTAL		$1,278,399	$0	$1,578,399

University of California, Riverside	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Byus, Craig Unique Genes Expressed in Cancer Cells	2.0	$150,000	$0	$150,000

University of California, San Diego	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Andersen, Bogi New Gene Regulation Factor, LMO-4, in Breast Cancer	2.0	$190,000	$0	$190,000
MacLeod, Carol The Role of Nitric Oxide and Arginine in the Normal and Tumorous Breast	2.0	$200,000	$0	$200,000
Xu, Yang The Regulation of p53 Activity in Breast Cancer	2.0	$181,560	$0	$181,560
SUBTOTAL		$571,560	$0	$571,560

University of California, San Francisco	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Beyene, Yewoubdar Beliefs and Risks of Breast Cancer Among African Immigrants	2.0	$112,620	$0	$112,620
Campbell, Michael HER2/Neu DNA Vaccines for Breast Cancer	2.0	$197,249	$0	$197,249
Lieberman, Morton Effectiveness of Electronic Support Groups for Breast Cancer	1.0	$100,000	$0	$100,000
Tripathy, Debasish Laboratory Testing of Chinese Herbs Used for Breast Cancer	1.0	$95,593	$0	$95,593
Wrensch, Margaret Marin County Breast Cancer Study of Adolescent Risk Factors	2.5	$284,905	$0	$284,905
SUBTOTAL		$790,367	$0	$790,367

University of Southern California	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Bernstein, Leslie Postmenopausal Breast Cancer: Obesity and the Leptin Receptor Gene	1.0	$74,938	$47,586	$122,524
Hamilton, Ann Breast Cancer Susceptibility Genes in Very High Risk Women	1.0	$80,243	$50,954	$131,197
Henderson, Brian IGF System and Breast Cancer in Postmenopausal Women	1.0	$74,956	$47,597	$122,553
Meyerowitz, Beth Breast Cancer Survivorship: Partner's Role in Recovery	3.0	$468,018	$150,320	$618,338
Press, Michael Can Molecular Markrs Predict Response to Adjuvant Therapy?	3.0	$312,670	$198,085	$510,755
Williams-Hill, Donna Exercise, Hormones and Breast Cancer Prevention	1.0	$87,126	$55,325	$142,451
Wu, Anna Estrogen-metabolizing Genes, Soy and Breast Cancer in Asians	3.0	$1,023,306	$646,221	$1,669,527
SUBTOTAL		$2,121,257	$1,196,088	$3,317,345

Women's Cancer Resource Center	DURATION	DIRECT COST	INDIRECT COST	TOTAL
Estrin, Diane Returning to Work and Quality of Life After Breast Cancer	1.0	$74,910	$11,237	$86,147
Eversley, Rani (Sub-contract to Women's Cancer Resource Center)	1.0	$0	$0	$0
SUBTOTAL		$74,910	$11,237	$86,147